Low rate of cardiovascular AEs with adjuvant letrozole, tamoxifen

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1182, 2007-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective

By Karnon Jonathan

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 237-250

Adis International

Access to resources Recommend Favorite

Adjuvant letrozole worth the extra costs . . .

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Adjuvant letrozole worth the extra costs . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Letrozole after tamoxifen decreases BMD in breast cancer

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Letrozole superior to tamoxifen in advanced breast cancer

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite